Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion type Assertion NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_head.
- NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion description "[Since COX-2 inhibitors have been demonstrated to interfere with tumorigenesis and apoptosis, COX-2 and its gene product may be attractive targets for therapeutic and chemoprotective strategies in colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_provenance.
- NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion evidence source_evidence_literature NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_provenance.
- NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion SIO_000772 11469677 NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_provenance.
- NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion wasDerivedFrom befree-2016 NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_provenance.
- NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_assertion wasGeneratedBy ECO_0000203 NP324942.RA3C04XvGJq1neqmxXCu-DPXRoN1FWZ2ciyaGO9c2_N5A130_provenance.